These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

995 related items for PubMed ID: 17693420

  • 1. The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors.
    Rugo HS.
    Ann Oncol; 2008 Jan; 19(1):16-27. PubMed ID: 17693420
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
    Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.
    Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
    Mouridsen HT, Robert NJ.
    Eur J Cancer; 2005 Aug; 41(12):1678-89. PubMed ID: 16098456
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Challenges in the endocrine management of breast cancer.
    Mouridsen HT, Rose C, Brodie AH, Smith IE.
    Breast; 2003 Aug; 12 Suppl 2():S2-19. PubMed ID: 14659138
    [Abstract] [Full Text] [Related]

  • 10. A decade of letrozole: FACE.
    O'Shaughnessy J.
    Breast Cancer Res Treat; 2007 Aug; 105 Suppl 1(Suppl 1):67-74. PubMed ID: 17912637
    [Abstract] [Full Text] [Related]

  • 11. Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.
    Mouridsen HT, Robert NJ.
    MedGenMed; 2005 Aug 24; 7(3):20. PubMed ID: 16369246
    [Abstract] [Full Text] [Related]

  • 12. Are aromatase inhibitors superior to antiestrogens?
    Howell A, Buzdar A.
    J Steroid Biochem Mol Biol; 2005 Feb 24; 93(2-5):237-47. PubMed ID: 15860266
    [Abstract] [Full Text] [Related]

  • 13. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C, Keam SJ.
    Pharmacoeconomics; 2006 Feb 24; 24(5):495-517. PubMed ID: 16706574
    [Abstract] [Full Text] [Related]

  • 14. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ, Dawson C, Lawrence DH, Bliss JM.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003370. PubMed ID: 17253488
    [Abstract] [Full Text] [Related]

  • 15. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
    Morandi P, Rouzier R, Altundag K, Buzdar AU, Theriault RL, Hortobagyi G.
    Cancer; 2004 Oct 01; 101(7):1482-9. PubMed ID: 15378476
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R.
    Eur J Surg Oncol; 2008 Jul 01; 34(7):746-55. PubMed ID: 18296017
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.
    Tobias JS.
    Ann Oncol; 2004 Dec 01; 15(12):1738-47. PubMed ID: 15550578
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.
    Michaud LB.
    Am J Health Syst Pharm; 2005 Feb 01; 62(3):266-73. PubMed ID: 15719584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.